Clinical Trial Update: Telegram Messenger Support for Smoking Cessation After Heart Attack [NA]

View source ↗

Summary

A clinical trial update from ITMO University evaluates Telegram-based support for smoking cessation in patients after a myocardial infarction. The study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Snippet

Sponsor: ITMO University | Conditions: Myocardial Infarction (MI), Tobacco Use | NA | Status: NOT_YET_RECRUITING